These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9516089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dornase-alfa (DNase, Pulmozyme) for cystic fibrosis.
    MacConnachie AM.
    Intensive Crit Care Nurs; 1998 Apr; 14(2):101-2. PubMed ID: 9814214
    [Abstract] [Full Text] [Related]

  • 5. The use of recombinant human dornase alfa in CF.
    Cox C.
    Paediatr Nurs; 1995 Nov; 7(9):29-31. PubMed ID: 8705343
    [No Abstract] [Full Text] [Related]

  • 6. Dornase alfa therapy in cystic fibrosis: who should get it?
    Kanga JF.
    Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
    [No Abstract] [Full Text] [Related]

  • 7. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
    Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.
    Arch Pediatr; 1998 Apr; 5(4):371-7. PubMed ID: 9759155
    [Abstract] [Full Text] [Related]

  • 8. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 9. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun; 63(6):705. PubMed ID: 9687230
    [No Abstract] [Full Text] [Related]

  • 10. Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ.
    J Pediatr; 1999 Jun; 134(6):734-9. PubMed ID: 10356143
    [Abstract] [Full Text] [Related]

  • 11. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
    McCoy K, Hamilton S, Johnson C.
    Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
    [Abstract] [Full Text] [Related]

  • 12. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.
    Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, Hodson ME.
    Respiration; 2001 Oct; 68(2):160-4. PubMed ID: 11287830
    [Abstract] [Full Text] [Related]

  • 13. The overuse or underuse of dornase alfa.
    Shah PL, Hodson ME.
    Curr Opin Pulm Med; 1997 Nov; 3(6):410-3. PubMed ID: 9391759
    [Abstract] [Full Text] [Related]

  • 14. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM, Anderson L.
    Pharmacotherapy; 1996 Nov; 16(1):40-8. PubMed ID: 8700791
    [Abstract] [Full Text] [Related]

  • 15. The role of dornase alfa in the treatment of cystic fibrosis.
    Cramer GW, Bosso JA.
    Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dornase alpha and survival of patients with cystic fibrosis.
    McIntyre AM.
    Hosp Med; 1999 Oct; 60(10):736-9. PubMed ID: 10656067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.